Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of oral lorazepam in paediatric ICU patients
NL-OMON24356Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lorazepam in iatrogenic withdrawal syndrome (IWS) and Sedation requirement, sponsored by Erasmus MC. Primary endpoint: Pharmacokinetic parameters. Planned start Aug 2015; status: not yet recruiting.
02
Drugs
lorazepam
03
Conditions
iatrogenic withdrawal syndrome (IWS)Sedation requirement
Beyond the preview
Go deeper on NL-OMON24356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24356.